Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
Más filtros











Intervalo de año de publicación
1.
Clin Immunol ; 265: 110300, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38950722

RESUMEN

A comprehensive analysis of spatial transcriptomics was carried out to better understand the progress of halo nevus. We found that halo nevus was characterized by overactive immune responses, triggered by chemokines and dendritic cells (DCs), T cells, and macrophages. Consequently, we observed abnormal cell death, such as apoptosis and disulfidptosis in halo nevus, some were closely related to immunity. Interestingly, we identified aberrant metabolites such as uridine diphosphate glucose (UDP-G) within the halo nevus. UDP-G, accompanied by the infiltration of DCs and T cells, exhibited correlations with certain forms of cell death. Subsequent experiments confirmed that UDP-G was increased in vitiligo serum and could activate DCs. We also confirmed that oxidative response is an inducer of UDP-G. In summary, the immune response in halo nevus, including DC activation, was accompanied by abnormal cell death and metabolites. Especially, melanocyte-derived UDP-G may play a crucial role in DC activation.


Asunto(s)
Células Dendríticas , Melanocitos , Nevo con Halo , Humanos , Células Dendríticas/inmunología , Células Dendríticas/metabolismo , Melanocitos/metabolismo , Melanocitos/inmunología , Nevo con Halo/metabolismo , Nevo con Halo/inmunología , Uridina Difosfato Glucosa/metabolismo , Vitíligo/inmunología , Vitíligo/metabolismo , Masculino , Femenino , Adulto , Apoptosis , Linfocitos T/inmunología , Linfocitos T/metabolismo , Adulto Joven , Adolescente
2.
Sci Rep ; 14(1): 16580, 2024 07 17.
Artículo en Inglés | MEDLINE | ID: mdl-39020008

RESUMEN

Vitiligo and halo nevus are immune-mediated skin diseases that have a similar pathogenesis and involve cellular cytotoxicity mechanisms that are not yet fully understood. In this study, we investigated the expression patterns of the cytolytic molecule granulysin (GNLY) in different cytotoxic cells in skin samples of vitiligo and halo nevus. Skin biopsies were taken from perilesional and lesional skin of ten vitiligo patients, eight patients with halo nevus and ten healthy controls. We analysed the expression of GNLY by immunohistochemistry in CD8+ and CD56+ NK cells. A significantly higher accumulation of GNLY+, CD8+ GNLY+ and fewer CD56+ GNLY+ cells was found in the lesional skin of vitiligo and halo nevus than in the healthy skin. These cells were localised in the basal epidermis and papillary dermis, suggesting that GNLY may be involved in the immune response against melanocytes. Similarly, but to a lesser extent, upregulation of GNLY+ and CD8+ GNLY+ cells was observed in the perilesional skin of vitiligo and halo nevus compared to healthy controls. In this study, we demonstrated for the first time an increased expression of CD8+ GNLY+ T lymphocytes and CD56+ GNLY+ NK cells in lesions of vitiligo and halo nevus, indicating the role of GNLY in the pathogenesis of both diseases.


Asunto(s)
Antígenos de Diferenciación de Linfocitos T , Células Asesinas Naturales , Nevo con Halo , Vitíligo , Humanos , Vitíligo/metabolismo , Vitíligo/patología , Antígenos de Diferenciación de Linfocitos T/metabolismo , Masculino , Nevo con Halo/metabolismo , Nevo con Halo/patología , Femenino , Adulto , Células Asesinas Naturales/metabolismo , Células Asesinas Naturales/inmunología , Persona de Mediana Edad , Piel/metabolismo , Piel/patología , Linfocitos T CD8-positivos/metabolismo , Linfocitos T CD8-positivos/inmunología , Melanocitos/metabolismo , Melanocitos/patología , Adulto Joven , Antígeno CD56/metabolismo , Estudios de Casos y Controles
3.
Cureus ; 15(11): e49465, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-38152824

RESUMEN

The halo nevus is characterized by a ring of depigmentation appearing around an acquired or congenital melanocytic nevus. When observed in children, halo nevi are generally not a cause of concern. However, adult-onset halo nevi have an associated risk of primary cutaneous melanoma that corresponds to the risk of melanoma in patients with atypical nevi or a personal/familial history of melanoma. Thus, new-onset halo nevi in adults requires close follow-up and monitoring for malignancy. Herein we present a case of an adult patient who received sequential digital dermoscopy, reflectance confocal microscopy, and pigmented lesion assay gene expression profiling to monitor two halo nevi over a three-month period.

4.
Clin Cosmet Investig Dermatol ; 16: 1003-1008, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37070000

RESUMEN

Perinevoid alopecia (PA) is a rare variant of alopecia areata (AA) associated with a central pigmented nevus. In this study, we reported two cases of PA and reviewed 14 cases from 11 studies in the literature. In one of our cases, PA was combined with a halo nevus and white terminal hairs were spared in the hair loss patch, which was rarely reported in the literature. It is implicated that antigens from melanocytes might be involved in the development of AA in PA.

5.
J Dermatol Sci ; 109(3): 136-142, 2023 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-36966028

RESUMEN

BACKGROUND: Halo nevus, also called Sutton's nevus, is a nevus cell nevus surrounded by vitiligo thought to be caused by a T-cell mediated immune response to the nevus antigen. The immune microenvironment is mysterious, however, as vitiligo often does not improve even when the nevus cells are removed. OBJECTIVES: To analyze the clinical course and immune microenvironment of patients with halo nevus who had undergone nevus excision. METHODS: We collected 54 halo nevus patients and performed multivariate analysis and immunohistochemical analysis, including multiplexed immune cell phenotyping and spatial single-cell analyses using the PhenoCycler® assay. RESULTS: Multivariate analysis revealed that only the presence or absence of vitiligo vulgaris at the time of consultation was associated with improvement in the surrounding vitiligo following excision. Expression of programmed death-ligand 1 in nevus cells was significantly higher in non-improved cases compared with improved cases. The PhenoCycler® assay revealed that CD107a-positive and CD21-positive cells were more prevalent in improved cases than in non-improved cases. In the improved cases, active cell-cell interactions, centered on CD21-positive cells, were observed, whereas in the non-improved cases, cell-cell interactions were sparse. Instead, a dense infiltration of CD8-positive cells and CD3 and CD4-positive cells was observed in non-improved cases. CONCLUSION: Elucidation of the immune microenvironment of halo nevus is also relevant to melanoma-associated vitiligo and will contribute to our understanding of tumor immunity.


Asunto(s)
Nevo con Halo , Nevo Pigmentado , Nevo , Neoplasias Cutáneas , Vitíligo , Humanos , Nevo con Halo/cirugía , Vitíligo/cirugía , Neoplasias Cutáneas/patología , Nevo Pigmentado/patología , Microambiente Tumoral
7.
Int J Trichology ; 14(2): 68-70, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35531486

RESUMEN

Halo nevus (HN) is benign skin condition with a central melanocytic nevus, surrounded by an area or halo of depigmentation. It is the result of immunological response of the body toward the nevus, which destroys the melanocytes in surrounding skin, leading to the depigmented halo. An increased frequency of HN in patients with vitiligo is observed. It is more commonly seen in children or young adults of either sex, particularly on the trunk, less commonly on the face, neck, and limbs. We present a rare case of HN which was present on the lower eyelid associated with poliosis, diagnosed with dermatoscopy.

8.
J Clin Med ; 10(14)2021 Jul 08.
Artículo en Inglés | MEDLINE | ID: mdl-34300213

RESUMEN

Immunotherapy with checkpoint inhibitors significantly improves the outcome for stage III and IV melanoma. Cutaneous adverse events during treatment are often reported. We herein aim to review the principal pigmentation changes induced by immune check-point inhibitors: the appearance of vitiligo, the Sutton phenomenon, melanosis and hair and nail toxicities.

9.
Australas J Dermatol ; 62(1): e24-e28, 2021 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-32812240

RESUMEN

BACKGROUND: The extent and disease severity, duration and other associated prognostic cofactors in vitiligo in adults may vary with the age of onset (before or after 10 years of age). OBJECTIVES: To compare extent and disease severity, duration and other cofactors in adults with early-onset and late-onset vitiligo. METHODS: The medical records of 408 (M:F 1:1.1) adults aged 20-75 years diagnosed with vitiligo between January 2016 and December 2019 were examined retrospectively. The extent and severity of vitiligo were defined. Characteristics of vitiligo with early onset and late onset were compared statistically and odds ratios calculated for risk assessment. RESULTS: 31 (7.6%, M:F 1:2.4) patients had early-onset vitiligo, and 377 (92.4%, M:F 0.8:1) patients had later-onset vitiligo. Compared to late onset, patients with early-onset vitiligo had a significant number of males (71% vs 45.9%), higher percentages of body surface area involvement and moderate to extremely severe disease (29% vs 10.6%), longer duration of disease (41.9% vs 9%), Koebner's phenomenon (48.4% vs 15.6%) and halo nevus (9.7% vs 1.9%). Differences between the two groups were not significant for types of vitiligo, family history of vitiligo and presence of cutaneous and systemic/autoimmune diseases. CONCLUSION: The adults, males in particular, with generalised vitiligo (>10% BSA involvement) appear to have an early onset and a prolonged clinical course. The presence of Koebner's phenomenon and halo nevus in patients with early-onset vitiligo was other poor prognostic factors compared to patients with late-onset vitiligo. The retrospective, hospital-based cross-sectional design and small sample size for stratification remain major limitations.


Asunto(s)
Edad de Inicio , Índice de Severidad de la Enfermedad , Vitíligo/complicaciones , Adulto , Anciano , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Retrospectivos , Factores Sexuales , Adulto Joven
10.
J Cutan Pathol ; 48(4): 519-525, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33184871

RESUMEN

BACKGROUND: Traditionally, most cutaneous nevi show a gradient of HMB45 (human melanoma black 45) and negative PRAME (preferentially expressed antigen in melanoma) immunostaining, while melanomas often show irregularly positive, diffusely positive or completely negative HMB45 expression, and PRAME immunopositivity. However, we have occasionally observed benign halo nevi with loss of HMB45 gradient, raising diagnostic consideration for melanoma. The purpose of this study was to elucidate the expression pattern of HMB45 and PRAME in nevi with the halo phenomenon (NHP). METHODS: PRAME and HMB45 staining patterns in 20 cases of NHP and 16 cases of conventional nevi were evaluated using light microscopy. An HMB45 gradient was defined as immunopositivity in only superficial melanocytes. HMB45 aberrant expression consisted of superficial and deep immunopositivity. RESULTS: Aberrant HMB45 expression was observed in 10 of 20 NHP (50%). A gradient of HMB45 staining was seen in most conventional nevi, with only one showing focal weak expression in the deep dermis (6.3%). All cases of NHP and conventional nevi showed essentially negative immunostaining by PRAME. CONCLUSION: Aberrant HMB45 expression in NHP is not uncommon and may be a diagnostic pitfall. Negative PRAME immunostaining may be a reassuring finding to help differentiate halo nevus from malignant melanoma.


Asunto(s)
Antígenos de Neoplasias/metabolismo , Nevo con Halo/diagnóstico , Nevo con Halo/metabolismo , Antígeno gp100 del Melanoma/metabolismo , Adolescente , Adulto , Niño , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Melanocitos/metabolismo , Melanocitos/patología , Melanoma/diagnóstico , Melanoma/patología , Microscopía/métodos , Persona de Mediana Edad , Nevo/patología , Nevo con Halo/patología , Nevo con Halo/ultraestructura , Nevo Pigmentado/patología , Estudios Retrospectivos , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/patología , Coloración y Etiquetado/métodos , Adulto Joven , Melanoma Cutáneo Maligno
11.
JAAD Case Rep ; 6(4): 326-328, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-32258311
13.
JAAD Case Rep ; 5(4): 317-318, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30976642
14.
Skin Appendage Disord ; 5(2): 94-96, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30815441

RESUMEN

Perinevoid alopecia has been described as an associated alopecia surrounding a pigmented nevus due to an inflammatory response against nevus structures. It is described as a part of other nevocentric phenomena in which a cellular inflammatory response against nevus antigens develops. A 35-year-old male presented with a unique area of non-scarring alopecia surrounding an asymptomatic, pigmented nevus with a 1-month evolution. Trichoscopic and histologic findings were compatible with alopecia areata (AA). One month after excision, hair regrowth was reported by the patient. We concluded that perinevoid alopecia is an extremely rare clinical presentation of AA associated with a central, pigmented nevus where a cellular inflammatory response is triggered against hair follicles, nevoid cells, and melanocytic structures.

15.
J Cosmet Laser Ther ; 21(2): 118-121, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-29741410

RESUMEN

BACKGROUND: Halo nevus (HN) is a rare dermatologic disorder characterized by typical whitish rim surrounding an existing melanocytic nevus resembling halo. It is a cosmetic problem that may be linked to vitiligo, and it is advised to remove these nevi in order to avoid development of vitiligo. OBJECTIVES: The aim of the present study is to evaluate the cosmetic outcome after nevus removal and leukoderma dermabrasion with epithelial graft followed by narrow-band ultraviolet B (NB-UVB) phototherapy as management of resistant halo nevi and avoidance of development of vitiligo. PATIENTS AND METHODS: Ten patients with persisting halo nevi were selected as candidates in this study. Superficial dermabrasion was carried out using proper diamond fraises on depigmented rim and then punch biopsy probes with suitable size were used to harvest the nevus. Thiersch graft was prepared and applied on the dermabraded depigmented area. After 1 week of the procedure, patients were exposed to NB-UVB twice weekly and were followed up for 3 months. RESULTS: Repigmentation was noticed in 2 weeks and was nearly fully accomplished in all 10 patients within the 3-month period. No other vitiligo lesions developed during this period in all patients except for one case. CONCLUSION: Excision of Sutton's nevus with combined dermabrasion and Thiersch grafting followed by phototherapy is a good aesthetic maneuver in treating halo nevi and helps in avoiding further vitiligo depigmentation.


Asunto(s)
Dermabrasión/métodos , Nevo con Halo/terapia , Fototerapia/métodos , Trasplante de Piel/métodos , Adolescente , Adulto , Niño , Terapia Combinada , Femenino , Humanos , Masculino , Nevo con Halo/cirugía , Adulto Joven
16.
Chinese Journal of Dermatology ; (12): 121-125, 2018.
Artículo en Chino | WPRIM (Pacífico Occidental) | ID: wpr-710344

RESUMEN

Objective To investigate clinical characteristics of halo nevus,and to explore factors influencing its treatment outcome.Methods A prospective study was conducted in 250 patients with halo nevus from February 2016 to November 2016 to analyze the factors influencing treatment outcomes.Results There were a total of 293 lesions in the 250 patients,including 219 (87.6%) patients with solitary lesions and 31 (12.4%) with multiple lesions.Among these lesions,154 (52.6%) occurred on the trunk,and 127 (43.3%) occurred on the face and neck.The diameters of the lesions ranged from 5 mm to 20 mm.Not all the halo nevi spontaneously subsided in 248 (99.2%) of the 250 patients,and 122 (48.8%) of the patients were complicated by vitiligo.Univariate logistic regression analysis showed that age,number of lesions,complication by vitiligo and therapeutic methods were factors influencing the treatment outcome of halo nevus.Multivariate logistic regression analysis revealed that age ≤ 19 years or ≥ 40 years,disease duration > 1 year,solitary lesions,absence of vitiligo and nevus removal were independent factors for effective treatment of halo nevus.Conclusions Most of halo nevi cannot subside spontaneously.CO2 laser or surgical excision combined with externally applied agents is effective for the treatment of halo nevus.For halo nevus patients without vitiligo,it's preferred to remove the halo nevi.For halo nevus patients with vitiligo,nevi should be removed in the stable stage of vitiligo.Relapse often occurs in patients with multiple halo nevi or large-area vitiligo,so close follow-up is needed.

18.
J Dermatol Sci ; 87(1): 50-59, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-28385330

RESUMEN

BACKGROUND: Vitiligo and halo nevus are two common T-cell-mediated skin disorders. Although autoimmunity has been suggested to be involved in both diseases, the relationship between vitiligo and halo nevus is not fully understood. OBJECTIVE: The aim of the current study was to investigate whether vitiligo and halo nevus share the same immunological and oxidative stress response. METHODS: Infiltrations of T cells, and expressions of chemokine receptors (CXCR3, CCR4, CCR5) and cytotoxic markers (Granzyme B, Perforin) in the lesions of vitiligo and halo nevus were examined by immunohistochemistry. Enzyme-linked immunosorbent assay was performed to analyze the expressions of chemokines in the serum samples and cytotoxic markers secreted by CD8+ T cells which were sorted from the peripheral blood mononuclear cells in healthy donors, vitiligo and halo nevus patients. Tissue levels of chemokine receptors and CXCR3 ligands in healthy controls, vitiligo patients and halo nevus patients were determined by qRT-PCR analysis. The percentages of CXCR3+ CD4+ T and CXCR3+ CD8+ T cells from the peripheral blood samples were examined by flow cytometry. Tissue and serum hydrogen peroxide (H2O2) concentrations were measured using H2O2 assay kit. RESULTS: Immunohistochemistry revealed a significant T-cell response, with pronounced dermal infiltrates of CD8+ T cells in vitiligo and halo nevus. The inflammatory cytotoxic markers such as Granzyme B and Perforin were also elevated in vitiligo and halo nevus, suggesting inflammatory responses in situ. By qRT-PCR and ELISA assay, we found significantly increased expressions of the chemokine receptor CXCR3 and its ligands, especially the accumulated CXCL10 in the skin lesions of vitiligo and halo nevus. Moreover, the level of H2O2, a key player involved in regulation of the immune response was significantly upregulated in the skin lesions of vitiligo and halo nevus. In addition, the increased H2O2 concentration correlated positively with CXCL10 level in skin lesions of vitiligo and halo nevus. CONCLUSIONS: These results demonstrate a H2O2-involved autoimmune phenotype in vitiligo and halo nevus, characterized by increased level of IFN-γ-inducible chemokine pair CXCL10-CXCR3, as well as a dense CD8+ T infiltration in the skin lesions, thus suggesting a similar pathogenesis of the two diseases.


Asunto(s)
Nevo con Halo/inmunología , Estrés Oxidativo , Vitíligo/inmunología , Linfocitos T CD8-positivos/inmunología , Quimiocina CXCL10/análisis , Humanos , Nevo con Halo/metabolismo , Fenotipo , Especies Reactivas de Oxígeno/metabolismo , Receptores CXCR3/análisis , Piel/patología , Vitíligo/metabolismo
19.
Semin Diagn Pathol ; 34(1): 99-107, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-27979335

RESUMEN

This review considers neoplastic lesions that originate in the skin, and which have the potential to imitate hematopoietic proliferations at a histological level. They include lymphoepithelioma-like carcinoma, Merkel cell carcinoma, benign lymphadenoma, pseudolymphomatous angiosarcoma, lymphadenoid dermatofibroma, lymphomatoid atypical fibroxanthoma, histiocytoid (epithelioid) hemangioma, and inflamed melanocytic lesions. The clinical and pathological features of those tumors are considered.


Asunto(s)
Diagnóstico Diferencial , Neoplasias Hematológicas/diagnóstico , Neoplasias Cutáneas/diagnóstico , Adenoma/diagnóstico , Carcinoma/diagnóstico , Histiocitoma Fibroso Benigno/diagnóstico , Humanos , Melanoma/diagnóstico , Sarcoma/diagnóstico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA